Some players in the pharmaceutical industry have appealed to government to include infusion drugs in the list of medicines that have been banned from import.
Government recently announced a ban on the importation of some 49 medicines in a bid to grow the industry, by boosting the capacity of local manufacturing companies, as well as providing employment opportunities.
The list of 49 medicines set to be produced locally include aluminum hydroxide or magnesium trisilicate suspension, amoxicillin capsules and suspension, aspirin or caffeine tablet, folic acid and tablet, cetizine tablet, co-trimoxazole tablet, diclofenac tablet and oral rehydration salt (ORS) among others.
In an interview with Citi Business News, the Managing Director of Intravenous Infusion PLC, David Klutse said a ban on infusion drugs would greatly be welcomed.
“The infusion drugs are not on the ban list and it is something that we want to through the Pharmaceutical Association of Ghana, encourage the government to add,” he said.
Mr. Klutse stressed that the importation of infusion drugs are minimal, compared to other drugs, hence the need for the ban.
“Infusions itself, because of its weight has a disincentive for people to bring it in, nonetheless people still bring some in and we want to appeal to the government through the Pharmaceutical Association of Ghana to have it stopped completely,” he stressed.
By: Anita Arthur/citibusinessnews.com/Ghana